Evonik goes beyond the boundaries of chemistry with its combination of innovative strength and leading technological expertise. The global chemical company, headquartered in Essen, Germany, is active in more than 100 countries and generated sales of €15.2 billion and earnings (adjusted EBITDA) of €2.1 billion in 2024. The common motivation of the approximately 32,000 employees: to provide customers with a decisive competitive advantage with tailor-made products and solutions as a superforce for industry, thereby improving people’s lives. In all markets. Every day.
At Evonik Health Care, our innovative cell culture solutions are designed to meet the needs of biopharma companies worldwide by allowing increased cell culture performance and more efficient manufacturing of life-saving biopharmaceutical drugs and cutting-edge treatments. We offer a broad portfolio of cell culture ingredients and related services as a technology platform which contributes to highly effective drug development. Our cell culture solutions can be used in the manufacturing of therapeutic proteins like monoclonal antibodies, as well as in the production of viral vectors for gene therapy and specific cells for cell therapy.
